AnatomyDiseasesChemicals and DrugsPsychiatry and Psychology
Amyloid NeuropathiesAmyloid Neuropathies, FamilialPrealbuminAmyloidosisAmyloidDiabetic NeuropathiesAmyloid beta-PeptidesSerum Amyloid A ProteinPeripheral Nervous System DiseasesAmyloid beta-Protein PrecursorPlaque, AmyloidHereditary Sensory and Motor NeuropathyIslet Amyloid PolypeptideCerebral Amyloid AngiopathyHereditary Sensory and Autonomic NeuropathiesOptic Neuropathy, IschemicSerum Amyloid P-ComponentPolyneuropathiesSural NerveAmyloid Precursor Protein SecretasesAlzheimer Disease

Operative risks of domino liver transplantation for the familial amyloid polyneuropathy liver donor and recipient: a double analysis. (57/93)

 (+info)

Combined heart-liver transplantation with extended cardiopulmonary bypass. (58/93)

We report a case of combined heart and liver transplantation for familial amyloid polyneuropathy. This is the first such combined transplant performed in Asia, and differs from previously described cases, in that cardiopulmonary bypass was continued at partial flow during liver transplantation in our case. This was done in order to provide haemodynamic support to the cardiac graft and to protect it from the impending reperfusion insult that frequently accompanies liver transplantation. The utility of this management course is discussed, along with its actual and potential complications. We also describe the impact of a lung-protective ventilation strategy employed during cardiac transplantation.  (+info)

Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathy. (59/93)

 (+info)

Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study. (60/93)

 (+info)

Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant. (61/93)

 (+info)

Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity. (62/93)

 (+info)

Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models. (63/93)

 (+info)

A new procedure for temporary auxiliary partial liver transplantation using living donor graft for patients with familial amyloid polyneuropathy. (64/93)

 (+info)